comparemela.com

Latest Breaking News On - Acute physiology - Page 4 : comparemela.com

Clinical evaluation of meropenem-vaborbactam for UTI

Clinical efficacy has been demonstrated and suggests the use of meropenem-vaborbactam for the treatment of cUTI is an option.

New-york
United-states
New-delhi
Delhi
India
America
American
Meropenem-vaborbactam
Monte-carlo
Asia-pacific
Centers-for-disease
American-society-for-microbiology

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial | Critical Care Medicine | JAMA

This secondary analysis of an ongoing adaptive platform trial examines the effect of multiple interventions for critically ill adults with COVID-19 on longer-te

United-kingdom
Nepal
India
Monash
South-australia
Australia
Saclay
France-general
France
Bristol
City-of
Paris

What are the long-term outcomes of critical COVID-19 patients?

Researchers assessed the long-term outcomes of critically ill coronavirus disease 2019 (COVID-19) patients.

Kobkit-chamchod-shutterstock
Chronic-health-evaluation
Multifactorial-adaptive-platform-for-community
World-health-organization-disability-assessment-schedule
Critically-ill-patients-with
Image-credit
Community-acquired-pneumonia
Discovery-industry-focus
Acute-physiology
Coronavirus-disease-covid-19
Covid-19

Association of blood glucose variability

Determining the association between glucose variability and sepsis-related disseminated intravascular coagulation .

China
Japan
Tongji
Sichuan
Shanghai
United-states
Belgium
Helsinki
Eteläuomen-läi
Finland
Yiwen
Yunnan

Tele-Intensive Care Unit Global Market Report 2022: Tele-ICU Partnership Yields Clinical and Administrative Benefits

/PRNewswire/ The "Tele-Intensive Care Unit (ICU) Market - Global Outlook and Forecast 2022-2027" report has been added to ResearchAndMarkets.com s offering..

India
United-states
Dublin
Ireland
America
Laxmi-kravia-techlabs
Apollo-telehealth
Laura-wood
Hicuity-health
Office-hours-call
Veeone-health
Research-methodology

vimarsana © 2020. All Rights Reserved.